Corrigendum to "From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides"

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Hōputu: Pukapuka
I whakaputaina: Elsevier, 2016-01-01T00:00:00Z.
Ngā marau:
Urunga tuihono:Connect to this object online.
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2865fb767dfa43a79a6adf30a4a91a53
042 |a dc 
245 0 0 |a Corrigendum to "From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides" 
260 |b Elsevier,   |c 2016-01-01T00:00:00Z. 
500 |a 2162-2531 
500 |a 10.1038/mtna.2016.104 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Molecular Therapy: Nucleic Acids, Vol 5, Iss C (2016) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2162253117300203 
787 0 |n https://doaj.org/toc/2162-2531 
856 4 1 |u https://doaj.org/article/2865fb767dfa43a79a6adf30a4a91a53  |z Connect to this object online.